Nissei Capital, a Japanese investment company, offers early- and later-stage venture investment services and solutions.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Sep 22, 2021
Wevnal
|
Series A | ¥600M | Advertising | — |
Aug 18, 2021
Sprocket
|
Series C | ¥760M | Customer Service | — |
Aug 10, 2021
Smart119
|
Series B | ¥306.75M | Artificial Intelligence | Yes |
Jan 23, 2020
minma
|
Series A | $282.15M | E-Commerce | — |
Aug 23, 2019
Smart119
|
Series A | ¥91M | Artificial Intelligence | Yes |
Nissei Capital has had 4 exits. Nissei Capital most notable exits include Kringle Pharma , HENNGE
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Dec 28, 2020 | Kringle Pharma | IPO | Biotechnology | Detail |
Oct 8, 2019 | HENNGE | IPO | Information Technology | Detail |
Jun 26, 2019 | crea-japan | M&A | Information Technology | Detail |
Mar 16, 2010 | CellSeed | IPO | Alternative Medicine | Detail |